Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Cash from Financing (Quarterly): -1.637B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.637B |
| June 30, 2024 | -847.90M |
| March 31, 2024 | -425.60M |
| December 31, 2023 | -926.10M |
| September 30, 2023 | -97.60M |
| June 30, 2023 | -303.50M |
| March 31, 2023 | -974.70M |
| December 31, 2022 | -1.331B |
| September 30, 2022 | -758.70M |
| June 30, 2022 | -779.60M |
| March 31, 2022 | -1.009B |
| December 31, 2021 | -349.20M |
| September 30, 2021 | -877.50M |
| June 30, 2021 | -685.50M |
| March 31, 2021 | -1.100B |
| December 31, 2020 | 149.10M |
| September 30, 2020 | -145.70M |
| June 30, 2020 | -584.30M |
| March 31, 2020 | -24.80M |
| December 31, 2019 | -464.40M |
| September 30, 2019 | -132.70M |
| June 30, 2019 | -531.80M |
| March 31, 2019 | -40.10M |
| December 31, 2018 | -576.20M |
| September 30, 2018 | -224.80M |
| Date | Value |
|---|---|
| June 30, 2018 | -168.50M |
| March 31, 2018 | -121.40M |
| December 31, 2017 | -639.20M |
| September 30, 2017 | -423.10M |
| June 30, 2017 | -255.10M |
| March 31, 2017 | -575.70M |
| December 31, 2016 | -44.80M |
| September 30, 2016 | -531.00M |
| June 30, 2016 | 5.890B |
| March 31, 2016 | 30.50M |
| December 31, 2015 | 923.50M |
| September 30, 2015 | -432.10M |
| June 30, 2015 | 222.40M |
| March 31, 2015 | -109.00M |
| December 31, 2014 | -13.70M |
| September 30, 2014 | -26.20M |
| June 30, 2014 | -112.90M |
| March 31, 2014 | -114.60M |
| December 31, 2013 | 1.009B |
| September 30, 2013 | -208.30M |
| June 30, 2013 | -114.30M |
| March 31, 2013 | 6.60M |
| December 31, 2012 | -126.24M |
| September 30, 2012 | -402.88M |
| June 30, 2012 | -174.31M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.637B
Minimum
Sep 2024
149.10M
Maximum
Dec 2020
-658.60M
Average
-722.10M
Median
Cash from Financing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -0.916M |
| Moderna Inc | 11.00M |
| Baxter International Inc | -146.00M |
| Gilead Sciences Inc | -1.379B |
| Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 826.50M |
| Cash from Investing (Quarterly) | 1.748B |
| Free Cash Flow | 1.893B |
| Free Cash Flow Per Share (Quarterly) | 0.6174 |
| Free Cash Flow to Equity (Quarterly) | 2.090B |
| Free Cash Flow to Firm (Quarterly) | 893.62M |
| Free Cash Flow Yield | 11.77% |